Supervised Pelvic Floor Muscle Training Improves Sexual Function and Diminishes Sexual Distress in Women with Relapsing-Remitting Multiple Sclerosis: A Randomised Controlled Study

• Published in: Journal of personalized medicine Vol. 14; no. 1; p. 88
• Main Authors: Zachariou, Athanasios, Zikopoulos, Athanasios, Sapouna, Vaia, Skentou, Chara, Kaltsas, Aris, Giannakis, Ioannis, Zachariou, Dimitrios, Dimitriadis, Fotios, Mamoulakis, Charalampos, Mai, Dung Ba Tien, Phuoc, Nguyen Ho Vinh, Takenaka, Atsushi, Sofikitis, Nikolaos
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-01-2024
• Subjects: Analysis; Biofeedback; Females; Greek language; Investigations; Multiple sclerosis; Nervous system; Neurophysiology; Nurses; Orgasm; Pelvis; Quality of life; Questionnaires; Sexual disorders; Statistical analysis; Tizanidine; Vagina; Women; Greece; randomised controlled trial; sexual dysfunction; women’s health; sexual function and distress; multiple sclerosis; pelvic floor muscle training
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm14010088

This study investigates the impact of pelvic floor muscle training (PFMT) on sexual function and distress in women with multiple sclerosis (MS), a prevalent chronic nervous system disorder associated with sexual dysfunction. This study's primary aim was to assess the effectiveness of PFMT at improving sexual function and alleviating sexual distress in this population. In a randomised controlled trial, 82 women with MS were divided into two groups: Group A (41 women) underwent 12 weeks of PFMT, while Group B (41 women) served as a control group with no intervention. Both groups were assessed at the beginning and end of this study using the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised (FSDS-R). Statistical analysis, including Chi-square tests, was employed to compare the outcomes between the two groups, with a
-value of less than 0.05 considered significant. The results revealed no significant differences in baseline sexual function and distress between the groups. However, at the conclusion of the 12-week period, Group A exhibited statistically significant improvements in nearly all domains of FSFI and FSDS-R compared to Group B, except in the pain domain. This study concludes that PFMT can effectively enhance sexual function and reduce sexual distress in women suffering from MS. These findings underscore the potential of PFMT as a therapeutic intervention in managing sexual dysfunction associated with MS.